Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Monocyte dysfunction as a previously unrecognized pathophysiological mechanism in ApoE-/- mice contributing to impaired arteriogenesis.

Tchaikovski V, Tchaikovski S, Olieslagers S, Waltenberger J.

Int J Cardiol. 2015;190:214-6. doi: 10.1016/j.ijcard.2015.04.188. Epub 2015 Apr 23. No abstract available.

2.

Increased expression of cystatin C and transforming growth factor β-1 in calcific aortic valves.

Yetkin E, Tchaikovski V, Erdil N, Alan S, Waltenberger J.

Int J Cardiol. 2014 Oct 20;176(3):1252-4. doi: 10.1016/j.ijcard.2014.07.199. Epub 2014 Aug 4. No abstract available.

PMID:
25124995
3.

Angiotensin receptor blockers and tumorigenesis: something to be (or not to be) concerned about?

Tchaikovski V, Lip GY.

Curr Hypertens Rep. 2012 Jun;14(3):183-92. doi: 10.1007/s11906-012-0263-x. Review.

PMID:
22467342
4.

TGF-β1/ALK5-induced monocyte migration involves PI3K and p38 pathways and is not negatively affected by diabetes mellitus.

Olieslagers S, Pardali E, Tchaikovski V, ten Dijke P, Waltenberger J.

Cardiovasc Res. 2011 Aug 1;91(3):510-8. doi: 10.1093/cvr/cvr100. Epub 2011 Apr 8.

PMID:
21478266
5.

A disintegrin and metalloprotease 10 is a novel mediator of vascular endothelial growth factor-induced endothelial cell function in angiogenesis and is associated with atherosclerosis.

Donners MM, Wolfs IM, Olieslagers S, Mohammadi-Motahhari Z, Tchaikovski V, Heeneman S, van Buul JD, Caolo V, Molin DG, Post MJ, Waltenberger J.

Arterioscler Thromb Vasc Biol. 2010 Nov;30(11):2188-95. doi: 10.1161/ATVBAHA.110.213124. Epub 2010 Sep 2.

PMID:
20814017
6.

Diabetes mellitus activates signal transduction pathways resulting in vascular endothelial growth factor resistance of human monocytes.

Tchaikovski V, Olieslagers S, Böhmer FD, Waltenberger J.

Circulation. 2009 Jul 14;120(2):150-9. doi: 10.1161/CIRCULATIONAHA.108.817528. Epub 2009 Jun 29.

PMID:
19564559
7.

Pregnancy-associated changes in the hemostatic system in wild-type and factor V Leiden mice.

Tchaikovski SN, van Vlijmen BJ, Cleuren AC, Thomassen MC, Tchaikovski V, Tans G, Rosing J.

J Thromb Haemost. 2009 Feb;7(2):312-8. doi: 10.1111/j.1538-7836.2008.03240.x.

8.

Flt-1 signaling in macrophages promotes glioma growth in vivo.

Kerber M, Reiss Y, Wickersheim A, Jugold M, Kiessling F, Heil M, Tchaikovski V, Waltenberger J, Shibuya M, Plate KH, Machein MR.

Cancer Res. 2008 Sep 15;68(18):7342-51. doi: 10.1158/0008-5472.CAN-07-6241.

9.

Noninvasive diagnosis of ruptured peripheral atherosclerotic lesions and myocardial infarction by antibody profiling.

Cleutjens KB, Faber BC, Rousch M, van Doorn R, Hackeng TM, Vink C, Geusens P, ten Cate H, Waltenberger J, Tchaikovski V, Lobbes M, Somers V, Sijbers A, Black D, Kitslaar PJ, Daemen MJ.

J Clin Invest. 2008 Aug;118(8):2979-85. doi: 10.1172/JCI32767.

10.

The molecular basis of VEGFR-1 signal transduction pathways in primary human monocytes.

Tchaikovski V, Fellbrich G, Waltenberger J.

Arterioscler Thromb Vasc Biol. 2008 Feb;28(2):322-8. Epub 2007 Dec 13.

PMID:
18079407
11.

Novel PDGFbetaR antisense encapsulated in polymeric nanospheres for the treatment of restenosis.

Cohen-Sacks H, Najajreh Y, Tchaikovski V, Gao G, Elazer V, Dahan R, Gati I, Kanaan M, Waltenberger J, Golomb G.

Gene Ther. 2002 Dec;9(23):1607-16.

Supplemental Content

Loading ...
Support Center